TECOGEN INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $27.1M | $22.6M | $25.1M | $25.0M | $24.4M |
| Cost of revenue | $17.2M | $12.7M | $14.9M | $13.9M | $12.8M |
| Gross profit | $9.8M | $9.9M | $10.2M | $11.1M | $11.6M |
| Research and development | $1.2M | $961,837 | $840,011 | $732,873 | $542,079 |
| Operating expenses | $18.1M | $14.4M | $14.6M | $13.4M | $12.8M |
| Operating income | -$8.2M | -$4.5M | -$4.4M | -$2.3M | -$1.2M |
| Interest expense | $150,289 | $90,304 | $16,050 | $16,255 | $14,238 |
| Pretax income | -$8.2M | -$4.7M | -$4.5M | -$2.4M | $3.8M |
| Income tax expense | $20,615 | $22,565 | $32,491 | $16,352 | $19,491 |
| Net income | -$8.2M | -$4.8M | -$4.6M | -$2.4M | $3.7M |
| Balance Sheet | |||||
| Cash and equivalents | $12.4M | $5.4M | $1.4M | $1.9M | $3.6M |
| Current assets | $28.9M | $22.1M | $20.3M | $22.0M | $25.0M |
| Total assets | $37.0M | $31.1M | $27.8M | $28.3M | $32.4M |
| Current liabilities | $9.3M | $16.8M | $10.5M | $7.7M | $8.8M |
| Total liabilities | $15.5M | $21.0M | $13.1M | $9.3M | $11.2M |
| Stockholders' equity | $21.6M | $10.2M | $14.7M | $19.1M | $21.2M |
| Cash Flow Statement | |||||
| Cash from operations | -$9.9M | $4.1M | -$817,810 | -$1.4M | $465,033 |
| Depreciation and amortization | $877,675 | $553,783 | $567,712 | $428,348 | $469,854 |
| Stock-based compensation | $348,029 | $172,987 | $250,394 | $334,149 | $202,431 |
| Capital expenditure | $400,781 | $969,163 | $46,851 | $314,879 | $91,451 |
| Free cash flow | -$10.3M | $3.1M | -$864,661 | -$1.7M | $373,582 |
| Impairments | $1.1M | $217,295 | $0 | $0 | $0 |
Shares outstanding 29.9M · Free float 58.4%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.